Sanaa Noubir is VP of Clinical Development at Rna Diagnostics. Her present role focuses on the development and management of clinical trials and research collaborations with clinical partners in oncology. The global research team composed of Rna Diagnostics and its various clinical partners is developing a molecular test that aims to predict early during treatment the efficacy of cancer drugs and support personalized medicine. Noubir holds a PhD in Genetics and Molecular Biology from the University of Paris Sud XI, Orsay, France. Prior to joining Rna Diagnostics in 2013, she held academic research and teaching positions in the fields of Genetics and Immunology at universities in Europe and Canada. Dr. Noubir also has an MBA from the Schulich School of Business, York University.
Women in Clinical Trials & Life Sciences: International Women’s Day 8 March 2023
- Discuss historical to present day underrepresentation of women in clinical trials
- Review of implications on health outcomes due to underrepresentation of women
- Explore strategies for improved inclusion of women in clinical trial
- Sharing a framework for creating a successful business
- Discovering the importance of team development and shared values
- Learn how to run a large scale international clinical trial when you are a small size Canadian biotech company
- Discover strategies to build a body of clinical and scientific evidence when funds are limited